Mycenax, in partnership with the Taiwan Parenteral Drug Association (TPDA), is proud to announce an insightful seminar: "Trends and Challenges in Aseptic Fill-Finish and Integrated Services." This event will feature leading experts from Mycenax Biotech Inc., OPTIMA packaging group, Körber, and SCHOTT, sharing their invaluable insights on the entire spectrum of drug product development – from initial formulation to advanced aseptic filling.

Seminar Highlights
Attendees will acquire crucial knowledge and practical strategies from Mycenax’s speakers:
▶️ Pei-Jiun Chen, Ph.D. (CEO and President, Mycenax): Discover "From Drug Substance to Drug Product: A One-Stop Solution," a comprehensive overview of the drug development journey.

▶️ Jheng-Liang Yao (Pharmaceutical Development Manager, Mycenax): Learn "Maximizing Filling Success: Formulation Development and Drug Product Process Optimization," focusing on critical elements for efficient and successful filling.

▶️ Henry Chen, Ph.D. (Manufacturing Science and Technology Principal Specialist, Mycenax): Understand "From Tech Transfer to Sterile Reality: Challenges in Scaling DP Processes to the Plant," offering real-world solutions for scaling drug product processes.


Exclusive Opportunity: Mycenax Aseptic Fill-Finish Line Tour

Beyond the presentations, participants will have the exclusive opportunity to visit Mycenax’s newly completed aseptic fill-finish line. This state-of-the-art facility represents a significant milestone in our integrated CDMO service offerings, showcasing cutting-edge biomanufacturing capabilities.

Secure your spot now: https://lnkd.in/gWF_saEq

Don't miss this chance to connect, learn, and contribute to advancements in aseptic fill-finish.